CRTC3 and colorectal carcinoma: We found that the TT genotype of the intron variant rs7495132 in the CRTC3 gene was associated with clinically relevant poorer CRC‐specific survival in both the discovery (hazard ratio [HR] = 1.97, 95% confidence interval [CI] = 1.41‐2.74, P = 6.1 × 10−5) and validation analysis (HR = 1.69, 95% CI = 1.03‐2.79, P = .038).